Skip to content
HOME Insights

Fact Sheet: Ncyte® Plate-Ready vCardiomyocytes

Discover Ncyte® Plate-Ready vCMs for faster experimental setups in cardiac research, offering high-purity, functional, and electrophysiologically active ventricular-like cardiomyocytes.
DOWNLOAD NOW
Screenshot 2026-03-11 at 10.47.41 AM

Discover Ncyte® Plate-Ready vCardiomyocytes

Human induced pluripotent stem cell (hiPSC)-derived ventricular cardiomyocytes provide a reliable in vitro system for mechanistic analysis, as well as drug safety and efficacy screening. Ncyte® Plate-ready vCardiomyocytes offer the same functional characteristics as standard Ncyte® cardiomyocytes but are delivered in an assay-ready format, eliminating the need for a multi-day pre-culture step and enabling faster experimental setup. 

Ncyte® Plate-ready vCardiomyocytes are fully functional and electrophysiologically active ventricular-like cardiomyocytes compatible with a wide range of functional assays such as MEA electrophysiology, imaging-based assays, contractility measurements, metabolic studies, and cardiotoxicity screening. 

 
Topics
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.

Download the fact sheet by filling out the form below: